Thorne P S, Hillebrand J, Magreni C, Riley E J, Karol M H
Toxicol Appl Pharmacol. 1986 Oct;86(1):112-23. doi: 10.1016/0041-008x(86)90404-7.
Four experiments were undertaken to explore the nature of pulmonary sensitivity which may result from inhalation of subtilisin aerosols. In the first study, immediate- and late-onset responses were identified. Groups of guinea pigs were exposed to atmospheres containing 0.15 to 15 mg/m3 bacterial subtilisin for 15 min/day on each of 5 consecutive days. Following an exposure-free period, reexposure to subtilisin at 1.9 mg/m3 for 20 min resulted in pulmonary responses characterized as "rapid shallow breathing." In some cases, reactions were severe and resulted in respiratory anaphylaxis; in one case, it was fatal. These responses usually occurred during the inhalation challenge or within 1 hr of challenge. However, late-onset reactions, maximum at 3-6 hr postchallenge, were occasionally observed. Results from the second series of experiments indicated that pulmonary responses were most prevalent in animals initially exposed to high concentrations of subtilisin (greater than 0.15 mg/m3) whereas no responses were observed in animals which had been exposed to 8.3 X 10(-3) or 41 X 10(-3) mg/m3 subtilisin. A third study indicated that exposure to 1.9 mg/m3 subtilisin for 20 min could result in pulmonary hypersensitivity. Additionally, when animals received subtilisin exposure on Days 1-5, pulmonary responses were equally severe whether elicited by inhalation challenge on Day 10 or on Day 17. Lastly, long-term exposure of animals to low levels of the enzyme did not result in any cases of pulmonary sensitivity even though the total cumulative exposure received by these animals when administered over a short period of time regularly induced sensitivity. The identification of a "threshold" concentration for sensitization in this animal model implies that it should be possible to recommend a safe industrial exposure level to subtilisin and thus prevent sensitization of exposed workers.
进行了四项实验,以探究吸入枯草杆菌蛋白酶气雾剂可能导致的肺部敏感性的本质。在第一项研究中,确定了即时和迟发性反应。将豚鼠分组,连续5天每天暴露于含有0.15至15毫克/立方米细菌枯草杆菌蛋白酶的大气中15分钟。在无暴露期后,再次暴露于1.9毫克/立方米的枯草杆菌蛋白酶中20分钟,会导致肺部反应,表现为“快速浅呼吸”。在某些情况下,反应严重并导致呼吸性过敏反应;有一例是致命的。这些反应通常发生在吸入激发期间或激发后1小时内。然而,偶尔会观察到迟发性反应,在激发后3至6小时达到最大值。第二项实验系列的结果表明,肺部反应在最初暴露于高浓度枯草杆菌蛋白酶(大于0.15毫克/立方米)的动物中最为普遍,而在暴露于8.3×10⁻³或41×10⁻³毫克/立方米枯草杆菌蛋白酶的动物中未观察到反应。第三项研究表明,暴露于1.9毫克/立方米的枯草杆菌蛋白酶中20分钟可能导致肺部超敏反应。此外,当动物在第1至5天接受枯草杆菌蛋白酶暴露时,无论在第10天还是第17天通过吸入激发引发,肺部反应都同样严重。最后,动物长期暴露于低水平的该酶不会导致任何肺部敏感情况,即使这些动物在短时间内定期接受的总累积暴露通常会引发敏感性。在该动物模型中确定致敏的“阈值”浓度意味着应该有可能推荐一个安全的工业枯草杆菌蛋白酶暴露水平,从而防止暴露工人致敏。